Your browser doesn't support javascript.
loading
IL-6 and cfDNA monitoring throughout COVID-19 hospitalization are accurate markers of its outcomes.
Bello, Salvador; Lasierra, Ana Belén; López-Vergara, Lucía; de Diego, Cristina; Torralba, Laura; de Gopegui, Pablo Ruiz; Lahoz, Raquel; Abadía, Claudia; Godino, Javier; Cebollada, Alberto; Jimeno, Beatriz; Bello, Carlota; Tejada, Antonio; Torres, Antoni.
Afiliação
  • Bello S; Department of Pulmonary Medicine, Miguel Servet University Hospital, CIBERES, Instituto de Investigación Sanitaria (ISS) Aragón, Avenida Isabel La Católica 1-9, 50009, Zaragoza, Spain. sbello@salud.aragon.es.
  • Lasierra AB; Department of Biochemistry, San Jorge Hospital, Huesca, Spain.
  • López-Vergara L; Department of Pulmonary Medicine, Miguel Servet University Hospital, CIBERES, Instituto de Investigación Sanitaria (ISS) Aragón, Avenida Isabel La Católica 1-9, 50009, Zaragoza, Spain.
  • de Diego C; Department of Pulmonary Medicine, Miguel Servet University Hospital, CIBERES, Instituto de Investigación Sanitaria (ISS) Aragón, Avenida Isabel La Católica 1-9, 50009, Zaragoza, Spain.
  • Torralba L; Department of Pulmonary Medicine, Miguel Servet University Hospital, CIBERES, Instituto de Investigación Sanitaria (ISS) Aragón, Avenida Isabel La Católica 1-9, 50009, Zaragoza, Spain.
  • de Gopegui PR; Intensive Care Unit, Miguel Servet University Hospital, Zaragoza, Spain.
  • Lahoz R; Department of Biochemistry, Miguel Servet University Hospital, Zaragoza, Spain.
  • Abadía C; Department of Biochemistry, Miguel Servet University Hospital, Zaragoza, Spain.
  • Godino J; Department of Cytometry and Cell Separation, Aragon Institute of Health Sciences (IACS), Zaragoza, Spain.
  • Cebollada A; Biocomputing Technical Scientific Service, Aragon Institute of Health Sciences (IACS), Zaragoza, Spain.
  • Jimeno B; Department of Cytometry and Cell Separation, Aragon Institute of Health Sciences (IACS), Zaragoza, Spain.
  • Bello C; Department of Radiology, Hospital Clínico Lozano Blesa, Zaragoza, Spain.
  • Tejada A; Intensive Care Unit, Miguel Servet University Hospital, Zaragoza, Spain.
  • Torres A; Servei de Pneumologia, Hospital Clinic, Universitat de Barcelona, IDIBAPS, ICREA, CIBERESUCICOVID, Barcelona, Spain.
Respir Res ; 24(1): 125, 2023 May 05.
Article em En | MEDLINE | ID: mdl-37147677

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ácidos Nucleicos Livres / COVID-19 Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ácidos Nucleicos Livres / COVID-19 Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article